You are here: Industry Insights > Sun Pharma

News List

Sun Pharma's SMO inhibitor Sonidegib at $175m about to be granted in China PharmaSources/Dopine
July 26, 2021
On July 13th, the status of Class 5.1 import application for "Sonidegib Phosphate Capsules" by Sun Pharmaceuticals/Jemincare progressed to "under review" at the NMPA, and it is foreseen that it will be duly approved soon.
Sun Pharma recalls 50,868 bottles of Metformin HCL ER tablets in US expresspharma
May 24, 2021
The tablets were produced at the company's Halol (Gujarat) based manufacturing plant and later distributed in the US by Cranbury (NJ) based Sun Pharmaceutical Industries.
Lilly signs licensing agreements with Cipla, Lupin and Sun Pharma for Baricitinib in India expresspharma
May 11, 2021
Eli Lilly and Company announced that it has issued royalty-free, non-exclusive voluntary licenses to established Indian pharmaceutical manufacturers of generic medicines, Cipla, Lupin and Sun Pharmaceutical Industries, who are collaborating with Lilly ...
Lupin, Sun Pharma, Jubilant Cadista recall generic medicines in US expresspharma
April 26, 2021
Lupin is recalling 17,814 bottles of Cefprozil, Sun Pharma is recalling 13,834 bottles of Riomet and Jubilant Cadista Pharmaceuticals is recalling 12,192 bottles of Itraconazole capsules.
Sun Pharma, Alembic recall products in the US market expresspharma
April 20, 2021
Sun Pharma is recalling 91,211 pre-filled syringes of Ganirelix Acetate injection and 2,520 bottles of Metformin HCl Extended-Release tablets while Alembic is recalling 12,288 bottles of Telmisartan Tablets.
Four pharma majors invest in ABCD Technologies expresspharma
March 26, 2021
Drug majors Sun Pharma, Lupin, Cadila Healthcare and Torrent Pharma on Thursday said they have subscribed to partnership interest in healthcare services firm ABCD Technologies which will be renamed as IndoHealth Services.
Sun Pharma, Dr Reddy’s, Aurobindo, Jubilant recall products in US expresspharma
March 15, 2021
The Indian firms have initiated recall of these products for various reasons including failed impurities/degradation specifications, failed dissolution specifications, presence of foreign tablets, illegible label etc.
Sun Pharma to acquire stake in WRS Bioproducts, Australia expresspharma
March 08, 2021
WRS Bioproducts develops novel technologies to produce supplements and nutraceutical ingredients from diverse algae species.
Sun Pharma to launch entire range of Brivaracetam for epilepsy treatment in India expresspharma
February 24, 2021
Brivaracetam is an anti-epileptic drug (AEDs) with fast onset of action and promising efficacy.
Sun Pharma recalls 36,275 cartons of testosterone injection in the US for labelling error expresspharma
February 08, 2021
Sun Pharmaceutical is recalling 36,275 cartons of a drug used to treat low testosterone levels in the US market for incorrect labelling.

Previous page 1 2 3 4 5 6 7 8 9 Next page